Telehealth Platform Offers Compounded GLP-1 Injections and Oral Tablets at $299/Month With No Contract as 100,000+ Patients ...

People who switched to the experimental daily GLP-1 pill orforglipron were able to maintain their weight loss after stopping ...

Below is a comparison of today’s most prescribed GLP-1 medications, including Ozempic and Trulicity, both widely used for ...

Protheragen, an ISO9001-certified supplier of pharmaceutical ingredients and specialty chemicals, today announced an expanded global supply of GLP-1 agonist APIs, including Semaglutide and Retatrutide ...

Novo Nordisk trades 32% below fair value with a 3.6% yield, semaglutide at 74% of sales, EPS rebound post '26, and pipeline ...

At the end of the day, GLP-1s can be a powerful tool for achieving your weight loss goals, but only if they're safe and ...

Lilly has now submitted a new drug application (NDA) for orforglipron to the FDA for use in adults with obesity.

China's drug regulator approved mazdutide as a Category 1 innovative drug in June for long-term weight management in adults with obesity and related metabolic conditions. According to Innovent, it is ...

Distilling that complexity into a handful of trends has been no small task. What follows is not a definitive forecast, but ...

These popular weight-loss drugs are already known for treating diabetes and helping people lose weight. Could they also add years to your life?

Dietitians Australia acknowledges today's announcement to list Wegovy on the Pharmaceutical Benefits Scheme (PBS) for people ...

Congress is leaving town for the holidays — and another year has gone by, with bipartisan pharmacy benefit manager legislation still on the flight deck.